Parental and Young Adult Perspectives on Investigative Genomic Tumor Profiling in High‐Risk, Recurrent, or Rare Pediatric Cancers: A Qualitative Study
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31667 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Kimberly A Pyke-Grimm und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing Research and Evidence-Based Practice, Center for Professional Excellence and Inquiry, Stanford Medicine Children's Health, Palo…. Hauptthemen laut MEDLINE: Parents, Neoplasms, Neoplasm Recurrence, Local, Genomics. Die Arbeit nennt 41 Literaturangaben. Gefördert von: State of California: the California Initiative to Advance Precision Medicine (CIAPM), now Health and Human Services Agency (CalHHS), Stanford Medicine Children's Health, Stanford University School of Medicine.
Abstract (Originalsprache)
Background
Although research has improved the prognosis of childhood cancer, many challenges remain, especially for high‐risk, recurrent, and rare cancers. The recognition that diverse cancer types may share molecular alterations that can be therapeutically targeted has stimulated “precision medicine” approaches in research. Understanding parent and patient interest in genomic‐derived therapeutic options in the clinical setting is limited and offers a potential for improved care.
Methods
A qualitative study was conducted to explore how young adult (YA) patients and parents of children and adolescent patients regard targeted therapy options. These patients had high‐risk, recurrent, or rare cancer for which there was no known curative therapy and were enrolled in a study evaluating investigational genomic tumor profiling. Clinical data were retrieved from medical records, and interviews were conducted.
Results
Seventeen participants were interviewed (11 parents and six YA patients). Six themes emerged: (i) Genomic Understanding, (ii) Partnerships in Decision‐Making, (iii) Connection with and Trust in Providers, (iv) Quality‐of‐Life (QOL) Considerations, (v) Understanding of Prognosis, and (vi) Nurturing Hope. Treatment decision‐making is complex and depends on the connection (with providers and others), understanding (of prognosis, genomic literacy), care goals (QOL considerations), and planning for the future (hope).
Conclusions
Participants favored partnership in decision‐making, expressed trust in their providers, and recognized the value of research. Engaging parents and YA patients in the planning of precision medicine translational research may be a path to designing an integrated research and care model that maximizes translational research implemented in real time, leading to improved outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing Research and Evidence-Based Practice, Center for Professional Excellence and Inquiry, Stanford Medicine Children's Health, Palo Alto, California, USA.
- Division of Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine, Department of Pediatrics, Stanford School of Medicine, Stanford, California, USA.
- Department of Molecular, Cell and Developmental Biology, UC Santa Cruz Genomics Institute, University of California, Santa Cruz, California, USA.
- Pediatric Oncology, Cancer Cell Immunotherapy, Stanford University, Palo Alto, California, USA.
- Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
- Genomics Institute, University of California Santa Cruz, Santa Cruz; Foundation to Advance Vascular Cures, Redwood City, California, USA.
ORCID-Profile: Kimberly A Pyke-Grimm, Sheri L Spunt
Förderung
- State of California: the California Initiative to Advance Precision Medicine (CIAPM), now Health and Human Services Agency (CalHHS)
- Stanford Medicine Children's Health
- Stanford University School of Medicine
- American Association for Cancer Research
- St. Baldrick's Foundation
- Unravel Pediatric Cancer
- Team G Childhood Cancer Foundation
- Live for Others Foundation
Zitieren
APA
Pyke-Grimm, K. A., Vaske, O. M., Li, A., Spunt, S. L., & Bjork, I. (2025). Parental and Young Adult Perspectives on Investigative Genomic Tumor Profiling in High‐Risk, Recurrent, or Rare Pediatric Cancers: A Qualitative Study. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31667
Vancouver
Pyke-Grimm KA, Vaske OM, Li A, Spunt SL, Bjork I. Parental and Young Adult Perspectives on Investigative Genomic Tumor Profiling in High‐Risk, Recurrent, or Rare Pediatric Cancers: A Qualitative Study. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31667
BibTeX
@article{PykeGrimm2025,
author = {Pyke-Grimm, Kimberly A and Vaske, Olena M and Li, Amy and Spunt, Sheri L and Bjork, Isabel},
title = {Parental and Young Adult Perspectives on Investigative Genomic Tumor Profiling in High‐Risk, Recurrent, or Rare Pediatric Cancers: A Qualitative Study},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31667}
}
EUVIMED